An announcement from CSPC PHARMA (HKEX: 01093) discloses that on June 22, 2026, the trustee of the company's 2026 Share Award Scheme purchased a total of 5.8 million shares in the market.
The acquisition was executed in accordance with the terms and conditions of the incentive plan. These shares are now held in trust for the benefit of the selected participants under the scheme.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments